These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
207 related items for PubMed ID: 12153365
1. Autoantibodies in lepromatous leprosy. Ochieng NA, Bwire MS, Orege PA, Nyawalo JO, K'Omollo JW. Afr J Health Sci; 1994 May; 1(2):79-83. PubMed ID: 12153365 [Abstract] [Full Text] [Related]
2. Serum immune complexes in erythema nodosum leprosum reactions of leprosy. Rao TD, Rao PR. Indian J Lepr; 1988 Apr; 60(2):189-95. PubMed ID: 3142953 [Abstract] [Full Text] [Related]
3. Serum immunoglobulins an autoantibodies during and after erythema nodosum leprosum (ENL). Sharma VK, Saha K, Sehgal VN. Int J Lepr Other Mycobact Dis; 1982 Jun; 50(2):159-63. PubMed ID: 6811448 [Abstract] [Full Text] [Related]
4. Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India. Pocaterra L, Jain S, Reddy R, Muzaffarullah S, Torres O, Suneetha S, Lockwood DN. Am J Trop Med Hyg; 2006 May; 74(5):868-79. PubMed ID: 16687695 [Abstract] [Full Text] [Related]
7. Determination of circulating IgG subclasses against lipoarabinomannan in the leprosy spectrum and reactions. Beuria MK, Mohanty KK, Katoch K, Sengupta U. Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):422-8. PubMed ID: 10700917 [Abstract] [Full Text] [Related]
8. Low serum HDL-cholesterol is associated with raised tumor necrosis factor-alpha during ENL reactions. Memon RA, Kifayet A, Shahid F, Lateef A, Chiang J, Hussain R. Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):1-11. PubMed ID: 9207748 [Abstract] [Full Text] [Related]
9. Serum proteome of leprosy patients undergoing erythema nodosum leprosum reaction: regulation of expression of the isoforms of haptoglobin. Gupta N, Shankernarayan NP, Dharmalingam K. J Proteome Res; 2007 Sep; 6(9):3669-79. PubMed ID: 17658739 [Abstract] [Full Text] [Related]
13. Increased level of urinary nitric oxide metabolites in leprosy patients during type 2 reactions and decreased after antireactional therapy. Mohanty KK, Gupta M, Girdhar BK, Girdhar A, Chakma JK, Sengupta U. Lepr Rev; 2007 Dec; 78(4):386-90. PubMed ID: 18309713 [Abstract] [Full Text] [Related]
14. Frequency and extent of thickening of the nucleated epidermis in leprosy lesions. Rea TH. Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):410-6. PubMed ID: 11332284 [Abstract] [Full Text] [Related]
15. ConA-induced suppressor cells in lepromatous leprosy patients during and after erythema nodosum leprosum. Sasiain MC, Ruibal Ares B, Baliña LM, Valdez R, Bachmann AE. Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):321-7. PubMed ID: 6227570 [Abstract] [Full Text] [Related]
17. In situ characterization of T lymphocyte subsets in the reactional states of leprosy. Modlin RL, Gebhard JF, Taylor CR, Rea TH. Clin Exp Immunol; 1983 Jul; 53(1):17-24. PubMed ID: 6223731 [Abstract] [Full Text] [Related]
18. Imbalances in T cell subpopulations in lepromatous leprosy. Wallach D, Cottenot F, Bach MA. Int J Lepr Other Mycobact Dis; 1982 Sep; 50(3):282-90. PubMed ID: 6216219 [Abstract] [Full Text] [Related]
19. Serum lymphocytotoxic activity in leprosy. Rasheed FN, Locniskar M, McCloskey DJ, Hasan RS, Chiang TJ, Rose P, de Soldenhoff R, Festenstein H, McAdam KP. Clin Exp Immunol; 1989 Jun; 76(3):391-7. PubMed ID: 2752595 [Abstract] [Full Text] [Related]
20. A study of antispermatozoal antibodies in leprosy. Gupta SC, Chhabra B, Mehrotra TN, Bajaj AK. Int J Lepr Other Mycobact Dis; 1982 Mar; 50(1):43-6. PubMed ID: 7200471 [Abstract] [Full Text] [Related] Page: [Next] [New Search]